1346576-39-3 Usage
Uses
Used in Organic Synthesis:
1H-Indole-4-carboxylic acid, 6-broMo-3-Methyl-1-(1-Methylpropyl)-, Methyl ester is used as a key intermediate in organic synthesis for the preparation of various chemical compounds. Its unique structure allows for versatile chemical reactions, making it a valuable component in the synthesis of complex organic molecules.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, 1H-Indole-4-carboxylic acid, 6-broMo-3-Methyl-1-(1-Methylpropyl)-, Methyl ester is utilized as a building block for the development of new drugs. Its presence in the molecular structure of certain pharmaceutical compounds contributes to their therapeutic properties, making it an essential component in drug discovery and design.
Used in Agrochemical Compounds:
1H-Indole-4-carboxylic acid, 6-broMo-3-Methyl-1-(1-Methylpropyl)-, Methyl ester also finds application in the agrochemical industry, where it serves as a precursor for the synthesis of various agrochemical compounds. Its unique chemical properties enable the development of effective pesticides, herbicides, and other agrochemical products.
Used in Biological Research:
Due to its potential biological activities, 1H-Indole-4-carboxylic acid, 6-broMo-3-Methyl-1-(1-Methylpropyl)-, Methyl ester is employed in biological research to study its interactions with biological systems. This research can lead to a better understanding of its potential therapeutic effects and applications in medicine and agriculture.
Check Digit Verification of cas no
The CAS Registry Mumber 1346576-39-3 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,4,6,5,7 and 6 respectively; the second part has 2 digits, 3 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 1346576-39:
(9*1)+(8*3)+(7*4)+(6*6)+(5*5)+(4*7)+(3*6)+(2*3)+(1*9)=183
183 % 10 = 3
So 1346576-39-3 is a valid CAS Registry Number.
1346576-39-3Relevant academic research and scientific papers
SUBSTITUTED BENZENE AND 6,5-FUSED BICYCLIC HETEROARYL COMPOUNDS
-
Paragraph 0655; 0666-0667, (2016/05/02)
The present invention relates to substituted benzene compounds and bicyclic heteroaryl compounds. The present invention also relates to pharmaceutical compositions containing these compounds and methods of treating cancer by administering these compounds and pharmaceutical compositions to subjects in need thereof. The present invention also relates to the use of such compounds for research or other non-therapeutic purposes.
1,4-PYRIDONE BICYCLIC HETEROARYL COMPOUNDS
-
Paragraph 0560; 0561, (2014/07/08)
The present invention relates to 1,4-pyridone bicyclic heteroaryl compounds. The present invention also relates to pharmaceutical compositions containing these compounds and methods of treating cancer by administering these compounds and pharmaceutical co
METHOD OF TREATMENT
-
Paragraph 0848, (2014/09/29)
The present invention relates to a method of treating T cell mediated inflammatory immune diseases or T cell mediated hypersensitivity diseases, which comprises administering to a human in need thereof an effective amount of a compound which inhibits EZH2 and/or EZH1, or a pharmaceutically acceptable salt thereof.
